Invention Grant
- Patent Title: Pharmaceutical composition for prevention or treatment of flavivirus infection
-
Application No.: US17051117Application Date: 2019-04-24
-
Publication No.: US12295967B2Publication Date: 2025-05-13
- Inventor: Cheol Hee Won , Dal Hee Min
- Applicant: LEMONEX INC. , SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- Applicant Address: KR Seoul; KR Seoul
- Assignee: LEMONEX INC.,SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- Current Assignee: LEMONEX INC.,SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- Current Assignee Address: KR Seoul; KR Seoul
- Agency: The PL Law Group, PLLC
- Priority: KR10-2019-0048075 20190424
- International Application: PCT/KR2019/004974 WO 20190424
- International Announcement: WO2019/209035 WO 20191031
- Main IPC: A61K31/7036
- IPC: A61K31/7036 ; A61K31/282 ; A61K31/47 ; A61K31/4706 ; A61K31/496 ; A61K31/536 ; A61K31/5415 ; A61K31/546 ; A61K31/661 ; A61K31/7048 ; A61K38/12 ; A61K38/14 ; A61P31/14

Abstract:
A method for treating a flavivirus infection includes administering to a subject in need thereof a composition which includes at least one of gentamicin sulfate, netilmicin, tobramycin, paromomycin, amikacin, capreomycin, trifluoperazine, dihydrostreptomycin, hydroxychloroquine, thioridazine HCl, efavirenz, miltefosine, nystatin, micafungin, bleomycin, resminostat, montelukast, norfloxacin, nedaplatin and cephalothin, which can exhibit excellent growth inhibition or killing effects of various species of flavivirus genus.
Public/Granted literature
- US20210228607A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF FLAVIVIRUS INFECTION Public/Granted day:2021-07-29
Information query
IPC分类: